TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Finox Biotech AB
Closing information (x1000 SEK)
Closing information | 2017/12 | 2016/12 | 2016/03 |
Turnover |
17,137
|
13,502
|
16,859 |
Financial expenses |
6
|
2
|
1 |
Earnings before taxes |
411
|
499
|
491 |
EBITDA |
957
|
759
|
766 |
Total assets |
4,007
|
4,916
|
4,189 |
Current assets |
4,007
|
3,757
|
3,193 |
Current liabilities |
3,375
|
4,382
|
3,847 |
Equity capital |
632
|
515
|
342 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
5
|
6
![]() |
6 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2016/03 |
Solvency |
15.8%
|
10.5%
|
8.2% |
Turnover per employee |
3,427
|
2,250
|
2,810 |
Profit as a percentage of turnover |
2.4%
|
3.7%
|
2.9% |
Return on assets (ROA) |
10.4%
|
10.2%
|
11.7% |
Current ratio |
118.7%
|
85.7%
|
83.0% |
Return on equity (ROE) |
65.0%
|
96.9%
|
143.6% |
Change turnover |
3,635
|
-3,357
|
6,090 |
Change turnover % |
27%
|
-20%
|
57% |
Chg. No. of employees |
-1
|
0
|
1 |
Chg. No. of employees % |
-17%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2016/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.